Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 41.3639.52115.92-94.85-1,170.52

What is the latest Core EBITDA Growth ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Growth ratio of BROOKS LABORATORIES is 41.36 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202641.36
Mar202539.52
Mar2024115.92
Mar2023-94.85
Mar2022-1,170.52

How is Core EBITDA Growth of BROOKS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 41.36
4.66
Mar2025 39.52
-65.91
Mar2024 115.92
Positive
Mar2023 -94.85
Negative
Mar2022 -1170.52 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Growth ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹171.2 Cr -12.5% 3.8% -50% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -0.4% -6.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr 0.9% -3.3% 39.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr 0.1% -7.2% 28.2% Stock Analytics
CIPLA ₹108,012.0 Cr -0.3% -4% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr 1.5% 3.1% 0.4% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-12.5%

3.8%

-50%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses